Call 911 now — don't message, don't read further — if you have swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe chest pain or pressure; fainting or collapse; a seizure; or you can't wake someone up.

When to Message Your GLP-1 Provider About Side Effects

By the Weight Loss Provider Guide editorial team · Last verified against FDA Medication Guides: August 8, 2026

This page cannot diagnose you or clear your next dose. A patient portal is not an emergency service.

Short version on when to message your GLP-1 provider about side effects: message today if a side effect is getting worse, keeps coming back, will not go away, or is stopping you from eating, drinking, sleeping, working, or keeping another medicine down. You do not need to wait a set number of days. Skip the message and call 911 for airway swelling, trouble breathing, severe chest pain or pressure, collapse, seizure, or someone who cannot be woken. Get urgent in-person care now for severe belly pain that will not let up, repeated vomiting with dehydration signs, sudden floaters or vision loss, or a swollen belly with vomiting and no gas. Call Poison Help if the amount or strength may be wrong.

Three things change that answer: which GLP-1 you're on (the FDA uses different wording for one gallbladder warning), how you actually reach your provider (an app is not a phone), and whether your dose went up recently.

Here's the part almost nobody tells you. There's a third phone number that sits between "message and wait" and "go to the ER" — and it is printed in every one of the five current Medication Guides we checked. We'll get to it in a minute.

Start here: which level are you?

→ Go to the full five-level symptom chart

When to message your GLP-1 provider about side effects: five reasons

Message your prescriber when a side effect is severe, worsening, keeps returning, is interfering with food or fluids, or simply won't go away. Current FDA Medication Guides for GLP-1 medications also tell patients to report any side effect that bothers them or does not resolve. You do not need to wait until a symptom becomes an emergency to report it.

Let's deal with the real reason you're hesitating.

It isn't that you don't know something's off. You know. You're hesitating because you don't want to look dramatic — and because some part of you is scared that if you say something, they'll take the medication away.

We'll handle that second fear head-on further down, because it deserves a real answer, not a pep talk.

For now: reporting a side effect is not a complaint. Researchers at the University of Pennsylvania analyzed 410,198 Reddit posts about semaglutide and tirzepatide between May 2019 and June 2025. Of the 67,008 users identified as saying they took one of these drugs, 43.5% described at least one side effect. Nausea led at 36.9%, then fatigue at 16.7%, vomiting at 16.3%, constipation at 15.3%, and diarrhea at 12.6%. (Sehgal et al., Nature Health, 2026. This is peer-reviewed social-media research based on self-reported forum posts, not a clinical trial or an incidence estimate. We use it here to show how common the conversation is, not to establish medical risk.)

Nearly half of that self-selected Reddit group. You are not the only one asking.

Five reasons to message today

1. It's severe — but you do not have one of the emergency patterns below. Not annoying. Severe.
2. It's getting worse, not better. Direction matters more than duration.
3. It keeps coming back — every week, after every shot.
4. It's blocking something — food, water, sleep, work, or another medicine you need to keep down.
5. You're unsure about your next dose. That's a real question and it deserves a real answer.

What real people are actually typing

These are public forum post titles, shared as language only — not as medical evidence:

"Side effects — how long to tough it out?" "Is this normal?" "Should I do my second shot?"

If one of those is basically your search history right now, you're in the right place, and you're not overreacting.

Why there's no safe "wait 24 hours" rule

FDA Medication Guides for GLP-1 medications do not set a universal waiting period before contacting a clinician. They base the instruction on severity, persistence, and which specific warning signs appear — using phrases like "severe," "will not go away," "tell your healthcare provider right away," and "get medical help right away." A fixed 24-hour or 3-day rule is not something the labels support.

A lot of pages will hand you a clean number. Wait 48 hours. Wait three days. Call after 24.

We're not going to do that, and here's why: those numbers aren't in the source documents. Somebody invented them because a number feels more helpful than a judgment call.

But a number in the wrong place is dangerous in both directions.

• Severe belly pain radiating to your back should not wait 24 hours. The labels say to stop the medicine and call right away.
• Mild nausea on day two of a new dose doesn't need a 24-hour clock at all.
• Nausea that's mild but has been slowly worsening for eight days is worth a message, even though no single hour of it was ever alarming.

The useful question isn't how long. It's these four:

1. How bad is it? Mild, or actually severe?
2. Which way is it heading? Better, the same, or worse?
3. Can you still drink and pee normally?
4. Is a red flag riding along with it? Severe localized pain, breathing trouble, fainting, yellow eyes, sudden vision change, or a swollen belly with no gas passing.

Answer those four and you can usually narrow down the right channel.

What does the FDA tell patients to do for GLP-1 side effects?

FDA Medication Guides do not use one instruction for side effects. They use several verbs: "get medical help right away," "stop using and call right away," "tell your provider right away," "call your provider," and "talk to your provider." The FDA does not call this a five-level system. The action map below is our editorial framework, built from the exact patient-facing words.

This is the part we haven't seen anyone else put together, so we did it ourselves.

We read the current DailyMed Medication Guides for Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo side by side on August 8, 2026. The FDA doesn't say "contact your provider" once and leave it there. The verb changes with the warning.

The label verb ladder

Once you see the ladder, the labels stop sounding like one long block of scary text and start sounding like instructions.

The five-drug wording check

Original verification: this table was assembled from the five current DailyMed Medication Guides and checked row by row on August 8, 2026. It is a compressed comparison, not a replacement for the guide in your box.

Now here's the strange part

Same warning signs. One different verb. Depending on which box is in your fridge.

Gallbladder symptoms — upper belly pain, fever, yellow skin or eyes, pale or clay-colored stools — are the one verified wording split in this five-drug set. Wegovy says call your provider. Ozempic, Zepbound, Mounjaro, and Foundayo say tell your provider right away.

The guides do not explain why Wegovy uses a different verb. That wording difference does not prove one drug is safer or riskier. Our action stays simple: contact a clinician today for the warning pattern, and get urgent in-person care now when the pain is severe or fever, jaundice, repeated vomiting, or pale stool joins it.

Persistent nausea, vomiting, or diarrhea is not a split. All five guides say to tell your provider right away when it does not go away.

Pancreatitis is not a split either. All five patient guides say to stop the medicine and call your provider right away for severe belly pain that will not go away, sometimes reaching the back.

What we think this means, and what we don't

We do not think one of these drugs is safer than another. You can't rank drugs by label wording.

What we do think: if you're going to be told "follow your Medication Guide," you deserve to know that the guides don't all use the same verb. Where the wording differs, this page uses the more urgent safe route rather than making you decode five documents while you feel sick.

What are the five GLP-1 side-effect contact levels?

GLP-1 side effects sort into five contact levels: log it, message today, get urgent in-person care now, call Poison Help, or call 911. The action depends on how severe the symptom is, whether it is improving, whether you can stay hydrated, and whether a specific warning sign is present alongside it.

How to read this chart: the symptom descriptions come from current FDA Medication Guides and from public-health sources including NIDDK, the American Diabetes Association, the National Eye Institute, America's Poison Centers, the CDC, and the 988 Suicide & Crisis Lifeline. The five levels are our editorial framework — not an FDA triage system, and not a diagnosis. Where the FDA says to stop a medicine or get help right away, we kept that instruction clear.

Working through a symptom that isn't on this list, or want the full emergency breakdown? Our GLP-1 side effects triage guide goes symptom by symptom on the ER and 911 side.

One honest limit

This page cannot tell you what's causing your symptom. It can't diagnose you, and it can't clear your next dose. No website can do that safely, and any page that acts like it can is selling you something.

What it can do is show you what the current FDA Medication Guides actually instruct, flag the symptom patterns that shouldn't sit in a message queue, and hand your clinician the exact facts they need to decide. That's the job.

→ Jump to the copy-ready message

Which side effects mean stop messaging and call 911?

Call 911 immediately for swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; fainting or collapse; a seizure; someone who cannot be woken; or severe low blood sugar with confusion or unconsciousness. FDA Medication Guides instruct patients to stop the medication and get medical help right away for serious allergic reactions. These are not portal-message situations.

Five things belong here and nowhere else.

Serious allergic reaction

Swelling of the face, lips, tongue, or throat. Trouble breathing. Trouble swallowing. Sudden widespread rash or hives. Fainting or severe dizziness. A very fast heartbeat.

These signs can worsen fast. Every GLP-1 Medication Guide we checked says the same thing: stop using or taking it and get medical help right away.

Don't send a message first. Don't wait to see if it settles.

Severe low blood sugar

The current Medication Guides flag a higher low-blood-sugar risk when a GLP-1 is combined with insulin or a sulfonylurea — older diabetes pills like glipizide and glyburide.

There's a clear line here. Shaky, sweaty, hungry, but awake and able to swallow safely? Follow the low-blood-sugar plan your diabetes clinician gave you, then report repeat episodes. Confused, seizing, unresponsive, or unable to swallow? That's a 911 call. The American Diabetes Association classifies severe hypoglycemia as an emergency.

Never put food or liquid in the mouth of someone who's unresponsive or seizing.

Collapse, seizure, or unable to wake after a suspected wrong dose

Poison Help is the right call when you're awake and stable. It is not the right call when someone has collapsed, is seizing, is struggling to breathe, or can't be woken. That's 911.

Severe chest pain or pressure

This is not a special GLP-1 rule. It is a general emergency rule.

New severe chest pressure, squeezing, fullness, or pain — especially with shortness of breath, sweating, nausea, faintness, or pain reaching the arm, jaw, back, or neck — is a 911 call. Don't decide it is "just reflux" from the medication and wait.

A mental health emergency

If you're having thoughts of harming yourself, call or text 988 (the Suicide & Crisis Lifeline), or call 911 if the danger is immediate.

The FDA's January 13, 2026 review did not find an increased risk of suicidal thoughts or behavior with GLP-1 medications and requested removal of that warning from affected labels. That finding does not change the action for a crisis. Don't spend energy trying to work out whether the medication caused it. Get support first.

What should you write to your GLP-1 provider?

A useful message to a GLP-1 prescriber includes the drug and form, the exact dose or tablet strength, the date and time of your last dose, when your symptom started, how severe it is, whether it is improving or worsening, whether you can keep fluids down, and a specific closing question. If you use a vial and syringe, also include the vial concentration and the amount drawn in milliliters or units. Vague messages tend to get vague replies.

Here's something we learned from reading real cases: the failure isn't always that nobody replies. Sometimes the failure is that a fuzzy question gets a confident wrong answer.

So make the question impossible to answer badly.

Copy this

Hi — I take [drug and form: pen, vial, or tablet] at [dose in mg or tablet strength].

I started on [date]. My last dose was [date and time]. My last dose increase was [date, or "none yet"].

My symptom is [what it is]. It started [when] and has lasted [hours or days]. It is [improving / the same / getting worse], and it's about a [0–10] out of 10.

Right now I [can / cannot] keep fluids down. I've vomited [number] times in the last 24 hours. My urine is [normal / darker / much less].

Other medicines I take: [list].

My question: should I take my next dose as planned, hold it, or do I need to be seen today?

Add this if you use a vial and syringe

The vial label says [concentration in mg/mL]. My written dose says [mg]. I drew up [mL or units] with a [syringe size] syringe. I can send a clear photo of the vial label and my written instructions through the secure portal.

Add this if you have pain

Where exactly it is. Whether it reaches your back or shoulder. Whether it's constant or comes in waves. Fever, yellow eyes, vomiting, swollen belly, and whether you're passing gas.

Why the dose-and-volume line matters more than anything else

That one line is there for a specific reason, and it's not a formatting preference.

In a June 1, 2026 investigation, KFF Health News reported the accounts of two women who were hospitalized after following telehealth instructions for compounded semaglutide. Karleigh McClain, 31, of Tennessee, said she was told to inject 2.21 mg weekly — nearly nine times a typical first dose. Leslie Gammon, 54, of North Carolina, said a refill arrived at a stronger concentration with instructions to inject three times the volume she had used before.

Both women said the amount looked wrong before they injected it.

These are reported patient accounts, not proof that every telehealth or compounded prescription has this problem. KFF also noted that bad outcomes are not unique to telehealth or to compounded drugs. The useful lesson is narrower: when the dose, concentration, and drawn volume sit in one sentence, a mismatch is much easier to see.

When you write only "my usual dose," nobody can check the math.

One more rule

Use the secure patient portal, not regular email, when you have the choice. And don't post your vial label, prescription, date of birth, address, or medical details in a public group or comment section.

→ What to do if the amount may be wrong

What if you might have taken the wrong compounded dose?

A suspected dosing error is a different problem from an ordinary side effect and needs a different response. Do not try to correct or offset the amount. Keep the vial, syringe, and label, then call Poison Help at 1-800-222-1222 — free, 24/7, staffed by clinicians — or call 911 for collapse, seizure, trouble breathing, or someone who cannot be woken.

Compounded GLP-1 medications are prepared by compounding pharmacies. They are not FDA-approved products, and the specific compounded product is not reviewed by the FDA for safety, effectiveness, or quality before sale the way Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo are. That's not a slur on them. It's a different legal and regulatory category. The FDA says a compounded drug may be appropriate when a patient's medical need cannot be met by an FDA-approved drug, or when the approved drug is not commercially available. It is not an FDA-approved generic version of the brand drug.

Why the measuring gets dangerous

FDA-approved GLP-1 products now come in several forms: tablets, prefilled single-dose pens, multi-dose pens, single-dose vials, and KwikPens. Those forms can still be used incorrectly.

The extra problem with many compounded injections is different: a multi-dose vial may require the patient to convert a prescribed amount in milligrams into a volume or syringe units, and concentrations can vary.

That's where it breaks:

• Your prescription is written in milligrams. Your syringe is marked in units or milliliters.
• A new vial or refill may have a different concentration, so the same number of syringe units can deliver a different drug amount.
• You're doing your first self-injection at 10pm and you've never used an insulin syringe before.

The FDA has received reports of compounded semaglutide dosing errors, some requiring medical attention or hospitalization. Its alert points to confusion between milligrams, milliliters, and units; different concentrations; and multiple-dose vials. The alert includes reports involving both patients and health care providers. America's Poison Centers reports the same pattern from the other end of the phone: with compounded products, patients have reported accidentally taking ten times the recommended dose because of confusing syringe measurement units.

What the current FDA count does — and does not — show

As of May 31, 2026, the FDA said it had received 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide.

Those numbers are not an incidence rate, and they do not prove the compounded drug caused every event. The FDA says causation cannot always be determined. It also says the count is likely incomplete because many state-licensed pharmacies are not required to submit adverse-event reports to the agency.

What to do, in order

1. Stop. Do not inject anything else. Do not try to "balance it out" next week.
2. Grab the evidence. Vial. Syringe. Box and pharmacy label. Your written instructions. Know how much you drew and when.
3. Call Poison Help: 1-800-222-1222. Free, confidential, 24/7/365. They handle non-emergencies too. They will tell you whether you need to go in.
4. Call 911 instead if there's collapse, a seizure, trouble breathing, or someone can't be woken.
5. Then message your prescriber and the pharmacy, so it goes on your record.

You are not in trouble. You are not the first person to make or catch this kind of mistake.

America's Poison Centers' current tracker lists 22,966 GLP-1 exposure cases from 2019 to 2025 and says calls tied to overdoses or side effects from injectable weight-loss drugs rose nearly 1,500% since 2019. It separately says 3,633 cases were managed in 2025 through April 30, its stated 2025 cutoff. These are poison-center exposure calls, not proof of causation and not a count of hospitalizations.

What if nobody answers your GLP-1 message?

A patient portal is not an emergency service. If you match a Level 3 or Level 5 pattern, do not wait for a reply — get in-person or emergency help now. If you are stable at Level 2 and the symptom worsens, your next dose is due, or the program misses its stated response time, escalate to the dispensing pharmacy, your primary care office or nurse line, Poison Help for dose questions, urgent care, or the ER as the symptom requires. Care should follow the severity of the symptom, not the response time of a telehealth company.

This is the question that sent most people to this page, and it's the one almost nobody answers.

The number that isn't in your app

Here's a detail we think is the most useful thing on this entire page.

The current Medication Guides for Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo all say that if you take too much, you can call your healthcare provider or Poison Help at 1-800-222-1222, or go to the nearest hospital emergency room right away.

The FDA put a phone number in all five guides. Most people have never dialed it.

America's Poison Centers describes the service as free, confidential, and available 24/7/365 — for emergencies and non-emergencies. A poison specialist answers. You don't need a telehealth account. You can save it right now by texting POISON to 301-597-7137.

For a scared person at 2am whose app shows a spinning wheel, that's the missing rung.

"24/7 access" still needs one more question

This is the distinction that matters most, and it's easy to miss.

Call-On-Doc currently says its secure online visits are available 24/7, licensed medical providers manage each visit, and most visits are completed within two hours. Those are specific visit-access claims.

They do not say that every existing patient's side-effect message is read by a licensed prescriber within two hours. "Start a visit anytime" and "a clinician will read this message by a guaranteed time" are two different promises.

We're not picking on them. Their current page is more specific than many, and that's exactly why they make a clean example.

Ask one question, and ask it in writing:

"Is a licensed prescriber reading this, or is this customer support?"

That question is the whole section. Save it.

Why it matters — the two documented cases

Go back to Karleigh McClain. According to KFF Health News, she tried to reach her doctor. She didn't get an immediate response. She said she called the company, and a "care team" representative confirmed the dosing instructions were correct. They weren't. She said she was hospitalized within 24 hours of her first injection, and a month later she still had an elevated heart rate and vision problems she felt were tied to the overdose.

Someone answered the phone. That person just wasn't the right person.

The wider numbers point the same way, with an important limit. A KFF Health News analysis of the FDA's adverse-event reporting system found that medication-error reports involving semaglutide, tirzepatide, dulaglutide, and liraglutide rose from just over 2,000 in 2020 to more than 25,000 in 2025. Frequent report types included an extra or incorrect dose, prescribing errors, and communication problems.

Those reports are self-reported signals. They cannot tell us the true error rate, prove causation, or show that telehealth caused each event.

Communication. Right there in the data.

The escalation ladder

When your message goes unanswered:

1. Level 3 or Level 5? Skip the list. Go now or call 911.
2. Level 2? Send the complete message. Write down the time.
3. Use the promised response time. If the program gives none, ask for one. Don't let a missed promise turn into open-ended waiting.
4. Ask the question. "Is a licensed prescriber reading this?"
5. Find the clinical phone number. Check the app, your emails, your prescription label, and your after-visit paperwork.
6. Call the pharmacy that filled it. Pharmacists can help with medication and re-dosing questions during pharmacy hours.
7. Call your primary care office or your health plan's nurse line, if you have one.
8. Poison Help: 1-800-222-1222 — especially when the amount, concentration, or timing may be wrong.
9. Urgent care or the ER based on the symptom pattern.

Loyalty to a telehealth brand is not a medical consideration. If your symptom needs a clinician now, use whichever safe door opens.

Will they take me off my GLP-1 if I report a side effect?

Reporting a side effect does not automatically mean permanent stop. Current labels include tolerability-based dose options. Wegovy injection explicitly allows a four-week delay in dose escalation when a dose is not tolerated, and Zepbound tells prescribers to consider a lower maintenance dose when a maintenance dose is not tolerated. The five current Medication Guides explicitly pair stop language with suspected pancreatitis and serious allergic reactions. A clinician can still hold, change, or stop treatment for other reasons based on your facts.

Let's say the quiet part out loud.

You've been waiting years for something that finally works. Your appetite is quiet for the first time in your adult life. You've lost weight. And now there's a symptom, and the little voice says: if I tell them, they'll take it away.

That fear is a real reason people sit on symptoms. It's not stupidity. It's not denial. It's someone protecting the thing that's working.

So here's the honest answer.

For a manageable side effect, there are more options than "push through" or "stop forever." A prescriber may keep you at the current dose longer, delay an increase, return to a previously tolerated dose when the product and your situation allow it, treat the symptom, order labs, switch the form or product, ask to see you in person, or stop treatment. Wegovy injection's four-week delay is a built-in label option. Slowing down is not a moral failure.

Sometimes the answer really is stop. We're not going to pretend otherwise. Suspected pancreatitis and serious allergic reactions are situations where the labels instruct stopping. Those aren't negotiable, and you wouldn't want them to be.

But here's the part worth sitting with. Staying silent doesn't protect your prescription. It delays the decision and can narrow your options. An early message may lead to a dose-plan conversation. Waiting until you can't keep fluids down can turn that same problem into IV fluids and an ER visit.

Speaking up is one way people protect safe access to treatment. Not how they lose it.

Should you take your next GLP-1 dose if you still feel bad?

There is no safe universal answer, because it depends on the medication, the form, the symptom, its severity, your other medicines, and your history. Do not double or split a dose, repeat an injection, or use a missed-dose rule to answer a side-effect question. Ask your prescriber before your next scheduled dose whenever symptoms are severe, persistent, worsening, or still affecting your food and fluid intake.

You'll find plenty of pages that tell you to just skip it. That's not advice anyone should give a stranger.

Ask before your next dose if:

• Your symptoms are still significant
• You had repeated vomiting or diarrhea this week
• You've barely eaten or had trouble drinking
• The symptom started right after a dose increase
• Another clinician treated you for it
• You may have taken the wrong amount
• You're just plain scared to take it

Don't confuse two different rules. Every product has instructions for what to do if you miss a dose. Those instructions were not written for someone who is currently sick. A missed-dose rule doesn't answer a side-effect question.

What your prescriber may suggest — and this is a list of possibilities, not a prediction: stay at this dose longer, delay the next increase, use a different tolerated dose when the label and your history allow it, push the date, treat the symptom, run bloodwork, switch products, see you in person, or stop.

Notice that "just keep going and tough it out" isn't the only option, and neither is "stop forever."

What happens after you message your GLP-1 provider?

A clinician will typically need your exact medication and dose, the timing of your last dose, the symptom's severity and direction, your hydration status, and your other medicines before advising. Depending on those answers, the response may be continued monitoring, a slower dose plan, symptom treatment, lab work, an in-person visit, or a change in treatment.

Knowing what's coming makes the message easier to send.

Questions they'll probably ask: What exactly did you take, and how much? Did your dose go up recently? How many times have you vomited? Can you keep liquids down? Are you peeing normally? Where is the pain, exactly? Any fever or yellowing? Do you take insulin or a sulfonylurea? When is your next dose due? Could there have been a measuring mistake? Could you be pregnant?

If you used the template above, you've already answered nine of those. That's the whole point — you skip a full round of back-and-forth, which on a slow portal can be an entire day.

One thing they will not do: score your willpower. A side effect is not a character flaw. The goal was never to see how much misery you can absorb.

Can GLP-1 side effects start after months on a stable dose?

Yes. New symptoms can appear well after the titration phase, though timing alone does not prove the medication caused them. A new or severe symptom after a stable stretch is worth reporting precisely because infections, gallbladder disease, another medication, a different vial concentration, or an unrelated condition can produce very similar symptoms.

Gastrointestinal reactions are most common during dose escalation, but there is no universal four-to-eight-week clock across every GLP-1 product. Ozempic, Wegovy injection, Zepbound, and Mounjaro use dose steps of at least four weeks. Wegovy tablets and Foundayo use steps of at least 30 days. Current labels tell prescribers to consider tolerability as the dose changes.

Which means a symptom that shows up in month six, on a dose you've handled fine since spring, is genuinely different information. It's not automatically "just the GLP-1." It might be related. It might not be. Either way, it's worth a message.

Ask yourself what else changed:

• New vial, new pen, or new pharmacy
• Different concentration on the label
• A dose increase in the past two months
• A new medicine, or a dose change to an old one
• An illness, a travel week, or a stomach bug going around
• A big change in what you're eating or drinking
• A recent surgery or procedure
• A possible pregnancy

And don't quietly go back to an old lower dose on your own to see if it helps. That decision belongs with the person who wrote the prescription.

Which special situations change when you should message?

Certain circumstances lower the threshold for contacting a clinician: taking insulin or a sulfonylurea, being pregnant or possibly pregnant, using an oral birth-control pill with tirzepatide or Foundayo, and vomiting up other prescription medicines. In each case the concern extends beyond the GLP-1 itself to how the symptom affects your other treatment.

If you take insulin or a sulfonylurea

Eating much less changes your blood sugar risk. That's the whole issue. Report repeated lows rather than just riding them out, and include your actual glucose readings, when you checked, what you'd eaten, and whether treating it worked. Your diabetes clinician may need to adjust something other than the GLP-1.

Follow the sick-day plan you were already given. We're not going to invent one here.

If you're pregnant or might be

Contact your prescriber today and say which exact product you take. The current label instructions are not identical.

This table summarizes label language. It does not replace a pregnancy or diabetes plan from your clinician.

If you can't keep other medicines down

This trips people up. You take your blood pressure pill, you vomit twenty minutes later, and you don't know whether it counted.

Don't guess and don't re-dose on your own. Call your pharmacist or prescriber. Whether it counted depends on the medicine, its form, and how long it stayed down.

If you're barely eating but technically still drinking

You don't have to wait until you can't swallow water. "I've eaten almost nothing for four days but I can sip liquids" is a completely legitimate reason to message today. Say it plainly and let them decide.

How can you report a GLP-1 side effect to the FDA yourself?

Patients can report a side effect, product-quality problem, or dosing error directly through the FDA MedWatch online form without going through a prescriber or manufacturer. The FDA's current reporting page also directs callers to 1-888-INFO-FDA (1-888-463-6332), then press 2 for MedWatch help or reporting instructions.

Do this after you've taken care of yourself, not instead of it.

Why bother? Because the reporting chain isn't airtight. In a March 5, 2026 warning letter, the FDA alleged postmarketing adverse-event reporting violations at Novo Nordisk after an agency inspection. A direct patient report does not depend on a provider, pharmacy, or manufacturer filing it for you.

The FDA uses MedWatch reports to look for safety signals, product problems, and use errors. A report by itself does not prove causation, but enough clear reports can show a pattern worth investigating.

Report a problem through FDA MedWatch

Frequently asked questions

Am I bothering my provider if it turns out to be nothing? No. Reporting a symptom that's severe, persistent, worsening, or worrying is a normal part of prescription care, and the Medication Guides specifically tell patients to report side effects that bother them or don't go away. A clinician would far rather answer a message about nothing than treat a problem at day nine.

How long should I wait before messaging? There's no universal number in the current Medication Guides. Message sooner when the symptom is severe, worsening, blocking food or fluids, or when you're unsure about your next dose.

Should I stop my GLP-1 because I feel nauseated? Not automatically and not by guessing. Current guides use explicit stop language for suspected pancreatitis and serious allergic reactions. Ordinary nausea is usually a dose-tolerability conversation, but nausea that is severe, worsening, or will not go away needs a prompt message.

I vomited once. Is that enough to message? One episode does not decide the level by itself. If you're otherwise stable, still drinking, peeing normally, improving, and have no severe pain or dose concern, log it and watch the direction. Message if vomiting repeats or worsens. Get urgent help if fluids will not stay down, urine turns dark or scarce, dizziness starts, or severe pain joins it.

I haven't had a bowel movement in three days. Is that an emergency? Days alone don't decide it. The urgent pattern is worsening pain or cramping plus a swollen or tender belly plus vomiting plus no gas passing. That combination needs in-person care now. Constipation without that cluster is not automatically an ER problem; message if it is severe, painful, worsening, or not resolving.

Does feeling sick mean it's working? No. You don't need to feel bad for the medicine to do its job, and there's no prize for suffering more.

Can I ask to stay at a lower dose? Yes, you can ask. Wegovy injection's label allows delaying an increase by four weeks when a dose isn't tolerated, and other labels use tolerability when choosing or changing doses. Your prescriber decides what's appropriate for your product and history, but asking is completely reasonable.

My symptoms started right after a dose increase. What should I say? Include your old dose, your new dose, the date of the change, when the symptom started, and when the next dose is due. That timeline is often all a clinician needs.

They told me to wait, but I'm getting worse. Now what? New symptoms override old advice. If you've crossed into Level 3 — you can't keep fluids down, have severe unrelenting pain, sudden eye-emergency signs, bleeding, or the obstruction cluster — go in. An earlier "wait and see" was based on how things looked earlier.

When should I call Poison Help instead of my provider? Any time the amount is in question: a suspected extra dose, a units-versus-milliliters mix-up, a vial at a different concentration, a repeated dose, or a reaction where you don't know how much you took. Poison Help is 1-800-222-1222, free, confidential, and available 24/7 for emergencies and non-emergencies.

Can a provider actually diagnose this over a message? Sometimes they can give safe next steps remotely. But anything that needs hands, imaging, bloodwork, IV fluids, or emergency care cannot be settled in a chat thread — and a good clinician will tell you that.

What did we verify for this page?

This guide was built by reading the current DailyMed Medication Guides for Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo side by side, then checking each emergency pattern against public-health sources. Community posts were used only to understand how people describe the problem, never to establish a medical threshold.

Primary sources

• Wegovy Medication Guide and full prescribing information — DailyMed
• Ozempic Medication Guide and full prescribing information — DailyMed
• Zepbound Medication Guide and full prescribing information — DailyMed
• Mounjaro Medication Guide and full prescribing information — DailyMed
• Foundayo Medication Guide and full prescribing information — DailyMed
• FDA alert on compounded injectable semaglutide dosing errors
• FDA's current concerns with unapproved GLP-1 drugs used for weight loss
• FDA MedWatch reporting program
• FDA warning letter to Novo Nordisk, March 5, 2026
• FDA's January 13, 2026 GLP-1 suicidality review

Other authoritative sources

• America's Poison Centers GLP-1 tracker
• National Eye Institute — retinal detachment warning signs
• NIDDK — intestinal-obstruction warning signs
• NIDDK — gastrointestinal-bleeding warning signs
• American Diabetes Association — severe hypoglycemia
• CDC — heart-attack warning signs
• 988 Suicide & Crisis Lifeline

Reporting and research

• KFF Health News / NBC News, "Telehealth Booms as Demand for GLP-1s Surges," June 1, 2026 — the McClain and Gammon accounts and the FDA adverse-event analysis
• Sehgal et al., "Self-Reported Side Effects of Semaglutide and Tirzepatide in Online Communities" — peer-reviewed Nature Health study based on self-reported forum data
• Call-On-Doc's current consultation page — current visit-access and provider claims, checked August 8, 2026

Provider source pages

• Ro weight-loss program pricing — membership prices, FDA-approved medication access, support features, and insurance concierge claims, checked August 8, 2026
• Embody official GLP-1 program page — displayed starting prices, plan terms, care-team messaging, provider review, coach role, and compounded-drug disclosure, checked August 8, 2026

What we created, and are responsible for

The five contact levels. The verb ladder framework. The five-drug wording comparison. The message template. The escalation ladder. Any place where we mapped a symptom to a channel that no FDA document assigns.

Limits that matter

• The five levels are not an FDA triage system.
• Poison-center exposure calls and FDA adverse-event reports do not prove that a drug caused an event and cannot be used as incidence rates.
• The poison-center tracker lists 2025 figures through April 30, 2025; more recent poison-center totals may exist.
• The KFF cases are reported patient accounts. They show how an error can happen, not how often it happens.
• Provider prices and support claims below were checked on the providers' own public pages. We did not mystery-shop clinical response times.

Found an error, or a newer label? Email hello@weightlossproviderguide.com with the product, the source, and the section. We update this page quarterly and after any new FDA Drug Safety Communication that changes the answer.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. This page is patient-safety content, built to be useful whether or not you ever click a link that earns us anything.

What does good GLP-1 provider support actually look like?

Before you need it, confirm four things about your GLP-1 program: whether a licensed prescriber reads side-effect messages, the stated response time in hours, whether a phone number reaches a human, and what the program tells patients to do after hours. Programs vary on all four, and the difference only becomes visible during a week when something goes wrong.

Read this part when your immediate concern is handled. If you're symptomatic right now, go back up to the ladder.

Still here? Then it's worth checking what you actually signed up for.

Couldn't answer three of those? That's genuinely worth knowing — and it's a fair reason to look around.

Here's our honest admission, and it applies to programs we recommend too: some telehealth programs use a care team or support queue before a prescriber sees a message. That can be normal. It stops being fine when the handoff is hidden or a non-clinical reply sounds like a clinical instruction. That's why the one question matters more than any brand name.

Affiliate disclosure: the two provider links below are affiliate links. We may earn a commission at no extra cost to you. That does not change the safety guidance above or the facts shown here.

Provider-stated support and price check

If you want FDA-approved medication and insurance help

Ro's program offers access to FDA-approved GLP-1 medications including Zepbound® and Foundayo™, matches LillyDirect and NovoCare cash pricing on medication, and offers an insurance concierge plus a free coverage checker for select medications. Membership is $39 for the first month, then $149/month on the month-to-month plan, or as low as $74/month on an annual plan paid upfront. Medication is billed separately. This is the better route of these two when you want an FDA-approved product and someone to fight the prior-authorization paperwork.

→ Check current coverage options and Ro terms

If a compounded cash-pay route is what you are choosing

Embody currently advertises compounded weekly injections starting at $79/month for GLP-1 and $129/month for GLP-1/GIP plans, with 24/7 care-team messaging and licensed-provider review. The displayed starting price depends on the plan term shown at checkout.

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before sale. Embody's own page also says its care coaches are not clinicians. That is exactly why the dosing-error section above exists, and why you should ask who reads a side-effect message before you need an answer.

→ See Embody's current plans and state availability

If your current program handed you a multi-dose vial with unclear instructions and no way to reach a clinician today, that's not a preference issue. That's a safety issue, and it's worth fixing.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

Use this only after your immediate symptom concern is resolved. If you have a red-flag symptom right now, contact emergency services or get in-person care instead.

Save these four numbers before you close this tab

Twenty seconds. Do it now, while you're thinking about it.

If that last row is blank because your program doesn't have one — that's your answer to the section above.

Related guides

• GLP-1 side effects: what's normal, what's serious, and when to go to the ER
• GLP-1 dehydration symptoms: warning signs and when to call
• GLP-1 electrolyte drinks: what to use when vomiting or diarrhea causes fluid loss
• GLP-1 constipation relief: what actually works
• GLP-1 delayed gastric emptying: symptoms and fixes

Last verified against FDA Medication Guides: August 8, 2026. Re-checked quarterly and after any new FDA Drug Safety Communication for GLP-1 receptor agonists.